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Abstract
Background: Mitochondrial DNA (mtDNA) mutations, which are present in all mitochondria-
containing cells, paradoxically cause tissue-specific disease. For example, Leber's hereditary optic
neuropathy (LHON) results from one of three point mutations mtDNA coding for complex I
components, but is only manifested in retinal ganglion cells (RGCs), a central neuron contained
within the retina. Given that RGCs use superoxide for intracellular signaling after axotomy, and that
LHON mutations increase superoxide levels in non-RGC transmitochondrial cybrids, we
hypothesized that RGCs regulate superoxide levels differently than other neuronal cells. To study
this, we compared superoxide production and mitochondrial electron transport chain (METC)
components in isolated RGC mitochondria to mitochondria isolated from cerebral cortex and
neuroblastoma SK-N-AS cells.
Results: In the presence of the complex I substrate glutamate/malate or the complex II substrate
succinate, the rate of superoxide production in RGC-5 cells was significantly lower than cerebral
or neuroblastoma cells. Cerebral but not RGC-5 or neuroblastoma cells increased superoxide
production in response to the complex I inhibitor rotenone, while neuroblastoma but not cerebral
or RGC-5 cells dramatically decreased superoxide production in response to the complex III
inhibitor antimycin A. Immunoblotting and real-time quantitative PCR of METC components
demonstrated different patterns of expression among the three different sources of neuronal
mitochondria.
Conclusion: RGC-5 mitochondria produce superoxide at significantly lower rates than cerebral
and neuroblastoma mitochondria, most likely as a result of differential expression of complex I
components. Diversity in METC component expression and function could explain tissue specificity
in diseases associated with inherited mtDNA abnormalities.
Background
Maternally inherited mitochondrial DNA (mtDNA) codes
for several mitochondrial proteins, primarily components
of the mitochondrial electron transport chain (METC).
Point mutations in mtDNA are causes of several diseases,
including mitochondrial encephalomyopathy with lactic
acidosis and stroke-like episodes (MELAS; position 3243
and others); neuropathy, ataxia, and retinitis pigmentosa
(NARP; position 8993); and Leber's hereditary optic neu-
ropathy (LHON; positions 11778, 3460, and 14484).
LHON is the most common hereditary optic nerve disease
causing severe visual loss. Most primary mutations code
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for proteins in METC complex I, although some secondary
mutations are in complex III [1]. A fundamental paradox
of diseases caused by mtDNA point mutations is that
although all mitochondria in the body have the same
mutation (when homoplasmic), the disease is usually
expressed in a restricted number of tissues. In the case of
LHON, the disease is almost exclusively manifested in ret-
inal ganglion cells (RGCs), the axons of which make up
the optic nerve. The reason for this cell-type specificity is
unknown, but presumably is related to a particular sus-
ceptibility of RGCs to a consequence of these mutations.
The effect of LHON mutations has been studied by pro-
ducing transmitochondrial cybrids in human cell lines,
demonstrating upregulation of some mtDNA transcripts,
e.g. aldose reductase [2]. LHON cybrids forced to use the
METC as their primary energy source by plating on glu-
cose-deficient galactose media, experience apoptotic
death and increased cytochrome c release [3]. Common
LHON mutations reduce the rate of respiration in LHON
cybrids and oxygen consumption [4,5]. Most importantly,
LHON cybrids have increased superoxide production
compared to wild-type cells [6].
Given that METC complexes I and III are the main sources
of basal superoxide production [7,8], it is possible that
aberrant production of superoxide from mutated METC
components would cause cell death. But why would
abnormalities in superoxide production be a mechanism
for the relatively specific effect of LHON mtDNA muta-
tions on RGCs? One explanation is the finding that RGCs
use superoxide as an intracellular signal for initiating the
apoptosis program after apoptosis [9,10], probably by
oxidizing critical sulfhydryls in signaling macromolecules
[11,12]. Supporting this theory, RGC death is triggered
when mitochondrial superoxide levels are increased by
knocking down mitochondrial superoxide dismutase
(SOD-2) [13]. Given that RGCs use superoxide for intrac-
ellular signaling, and that they are specifically affected in
a disease of specific mtDNA mutations, we examined
superoxide production in isolated RGC mitochondria,
using the RGC-5 RGC cell line. We show that mitochon-
dria derived from RGCs differ from cerebral and neurob-
lastoma mitochondria with respect to superoxide
production in the presence of complex-specific METC
substrates and inhibitors. Furthermore, we showed dis-
tinct patterns of METC component expression. Differ-
ences in superoxide production between neuronal cell
types could prevent aberrant apoptosis signaling [10], and
its disturbance with mtDNA mutations [6] could account
for tissue-specific expression of disease phenotype.
Results
Mitochondria can be isolated in bulk from RGC-5 cells
Because RGCs are post-mitotic and are present in rela-
tively small (105 cells/retina in the rat) numbers, it is
impractical to biochemically study RGC mitochondria in
bulk. Instead, we used the RGC-5 cell line, which when
Immunoblotting Measurement of Cytochrome c Oxidase in Differentiated and Undifferentiated RGC-5 Mitochondria Figure 1
Immunoblotting Measurement of Cytochrome c Oxidase in Differentiated and Undifferentiated RGC-5 Mito-
chondria. RGC-5 cells were differentiated with staurosporine. Isolated mitochondrial samples from undifferentiated and dif-
ferentiated mitochondria standardized for protein content were compared to corresponding mitochondria depleted samples 
for the presence of the mitochondrial transmembrane protein cytochrome c oxidase (COX), complex IV. Samples were immu-
noblotted with antibody to subunit 1 of complex IV. There was considerable purification of mitochondria compared to the 
mitochondria depleted samples for differentiated and undifferentiated RGC-5 cells. Differentiated RGC-5 cells had 2.5 times 
more cytochrome c oxidase than undifferentiated RGC-5 cells.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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differentiated are phenotypically similar to RGCs [14].
RGC-5 cells were grown in tissue culture and mitochon-
dria isolated. To assess purity of mitochondrial isolation,
mitochondrial-enriched and cytosolic fractions were
immunoblotted for cytochrome c oxidase, demonstrating
significant enrichment (Figure 1). Degree of mitochon-
drial purification was similar among cell-types, based on
quantitation with the fluorophore MitoTracker Green FM,
which reacts with mitochondrial free sulfhydryls. Mito-
chondrial samples exhibited similar relative fluorescence
values per mg protein (Figure 2).
Cerebral and RGC-5 cells differ in superoxide production 
with complex I substrates and after complex I inhibition
Superoxide was indirectly measured by detecting H2O2
generation over time as a result of spontaneous dismuta-
tion of superoxide by mitochondrial SOD-2 [15,16]. All
results are expressed as the mean ± SEM (in nmol/min/mg
protein) of 5 independent experiments, each in duplicate.
A typical experiment is depicted in Figure 3. The basal
level of superoxide production by RGC-5 mitochondria in
the absence of substrate was 0.030 ± 0.004 nmol/min/mg
protein, approximately one-seventh that of cerebral mito-
chondria (0.208 ± 0.033; p = 0.0017). Mitochondria were
then incubated with glutamate (10 mM) and malate (5
mM), which yields NADH and serves as a substrate for
complex I. In the presence of glutamate/malate there was
a small but significant increase in superoxide production
in cerebral (0.262 ± 0.028; p = 0.0042 compared to no
substrate) and RGC-5 mitochondria (0.046 ± 0.004; p =
0.0005 compared to no substrate). When samples were
then treated with the complex I inhibitor rotenone (6.7
µM) there was an insignificant change in the rate of super-
oxide production in both cerebral mitochondria (0.279 ±
0.035; p = 0.40 compared to glutamate/malate alone) and
RGC-5 mitochondria (0.048 ± 0.004; p = 0.24) after the
addition of rotenone. Nonetheless the rates of superoxide
production per mg protein in all conditions were signifi-
cantly lower in RGC-5 mitochondria than in cerebral
mitochondria (Table 1).
Cerebral and RGC-5 mitochondria differ in superoxide 
production with complex II substrate and after complex III 
inhibition
Mitochondria were incubated with succinate (10 mM),
which yields FADH2 and serves as a substrate for complex
II. In the presence of succinate, there was a small but sig-
nificant increase in superoxide production in cerebral
mitochondria (0.193 ± 0.027 to 0.216 ± 0.022; p = 0.04)
and RGC-5 mitochondria (0.028 ± 0.005 to 0.031 ±
0.005; p = 0.024). Subsequent treatment with the com-
Mitochondrial Quantification by MitoTracker Green Figure 2
Mitochondrial Quantification by MitoTracker Green. 
Isolated mitochondria preparations were corrected for pro-
tein concentration and then treated with MitoTracker 
Green, which becomes fluorescent in the lipid environment 
of active mitochondria. Fluorescence is in arbitrary units. 
Mitochondrial samples from RGC-5 cells, neuroblastoma 
cells, and cerebral cells exhibited similar fluorescence values, 
indicating similar amounts of mitochondria per unit protein.
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Table 1: Superoxide Production in Mitochondria from Cerebral, Neuroblastoma, and Undifferentiated RGC-5 Cells in the Presence of 
a Complex I Substrate and Inhibitor.
Cerebral Neuroblastoma RGC-5
N = 7 N = 7 N = 8
Mean SEM Mean SEM Mean SEM
Mitochondria 0.208 0.033 0.318 0.035 0.030 0.004
Glutamate/
Malate
0.262 0.028 0.560 0.054 0.046 0.004
Rotenone 0.279 0.035 0.383 0.050 0.048 0.004
The rates of superoxide production were determined after the addition of the complex I substrates glutamate (10 mM) and malate (5 mM) and the 
complex I inhibitor rotenone (6.7 µM). Superoxide was indirectly measured using the H2O2 probe Amplex Red in the presence of horseradish 
peroxidase (HRP). The values are given in nmol H2O2/min/mg protein ± standard error of the mean (SEM), with n being the number of independent 
samples for each mitochondria type.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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Superoxide Production in Cerebral, Neuroblastoma, and RGC-5 Mitochondria after Complex I Inhibition Figure 3
Superoxide Production in Cerebral, Neuroblastoma, and RGC-5 Mitochondria after Complex I Inhibition. 
Mitochondria isolated from cerebral, neuroblastoma, and undifferentiated RGC-5 cells were standardized for protein content 
and 50 µl were added to a well in a 96-well plate containing 50 µL Amplex Red (AR). Prior to the addition of solutions contain-
ing mitochondria a baseline of superoxide production was established by measuring the fluorescent product of H2O2 and AR, 
resorufin at approximately 10-second intervals. In a similar manner, production of superoxide was analyzed after the addition 
of the complex I substrates glutamate/malate and the complex I inhibitor rotenone. The mitochondrial superoxide production 
levels after the addition of glutamate/malate in cerebral cells were significantly higher than that of undifferentiated RGC-5 cells 
during basal metabolism, in the presence of glutamate/malate and after complex I inhibition with rotenone.
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Table 2: Superoxide Production in Mitochondria from Cerebral, Neuroblastoma, and Undifferentiated RGC-5 Cells in the Presence of 
a Complex II Substrate and a Complex III Inhibitor.
Cerebral Neuroblastoma RGC-5
N = 7 N = 7 N = 8
Mean SEM Mean SEM Mean SEM
Mitochondria 0.193 0.027 0.348 0.042 0.028 0.005
Succinate 0.216 0.022 0.307 0.024 0.031 0.005
Antimycin A 0.540 0.116 0.277 0.034 0.024 0.004
The rates of superoxide production were determined after the addition of the complex II substrate succinate (10 mM) and the complex III inhibitor 
antimycin A (0.5 µM). Superoxide was indirectly measured using the H2O2 probe Amplex Red in the presence of horseradish peroxidase (HRP). 
The values are given in nmol H2O2/min/mg protein ± standard error of the mean (SEM), with n being the number of independent samples for each 
mitochondria type.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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plex III inhibitor antimycin A (0.5 µM) resulted in a dra-
matic increase in the rate of superoxide production in
cerebral mitochondria (0.540 ± 0.116; p = .023 compared
to substrate alone), but not RGC-5 mitochondria (0.024 ±
0.004; p = 0.278). The rates of superoxide production in
all conditions were substantially greater in cerebral mito-
chondria than in RGC-5 mitochondria (Table 2). A typical
experiment is depicted in Figure 4.
Differentiation of RGC-5 cells does not normalize 
mitochondrial superoxide production
One explanation for the differences in mitochondrial
superoxide production between cerebral and RGC-5 cells
is the fact that RGC-5 cells are mitotic, while cerebral neu-
rons are post-mitotic. To address the possibility that dif-
ferences in proliferative state, metabolic activity, or degree
of differentiation affected superoxide production by mito-
chondria, we differentiated RGC-5 cells with the broad
spectrum kinase inhibitor staurosporine, which we have
previously shown to induce a RGC phenotype without
inducing apoptosis [14]. We then measured superoxide
production rates as above (Tables 3 and 4).
Basal mitochondrial superoxide production was similar in
undifferentiated and differentiated RGC-5 cells (0.030 ±
0.004 vs. 0.033 ± 0.004; p = 0.60). Mitochondria from
undifferentiated and differentiated RGC-5 were incubated
with glutamate/malate and subsequently treated with
rotenone. There was no significant difference between dif-
ferentiated and undifferentiated RGC-5 cells in the pro-
duction of superoxide after treatment with glutamate/
malate (0.046 ± 0.004 vs. 0.052 ± 0.003; p = 0.30) or
rotenone (0.048 ± 0.004 vs. 0.055 ± 0.002; p = 0.18).
Mitochondria from undifferentiated and differentiated
RGC-5 did not significantly differ in rates of superoxide
production when incubated with the complex II substrate
succinate (0.031 ± 0.005 vs. 0.037 ± 0.001; p = 0.30).
However, addition of antimycin A resulted in somewhat
more superoxide production in differentiated but not
undifferentiated RGC-5 cells (0.040 ± 0.002 vs. 0.024 ±
0.004; p = 0.001). Nonetheless, mitochondria from differ-
entiated RGC-5 cells had much lower superoxide produc-
tion than cerebral mitochondria under all treatment
conditions.
RGC-5 cells generate significantly less superoxide than 
neuroblastoma SK-N-AS cells with complex I and complex 
II substrates
The differences between superoxide generation from
RGC-5 and cerebral mitochondria could theoretically
reflect differences in the source of cells, a cultured cell line
in the former and fresh tissue in the latter. To rule out this
possibility, we compared superoxide generation in RGC-5
mitochondria to another neuronal cell line, the SK-N-AS
neuroblastoma line (Figures 3 and 4, Tables 1 and 2). As
with cerebral cells, the basal superoxide production was
much lower in RGC-5 cells compared to neuroblastoma
cells (0.030 ± 0.004 vs. 0.318 ± 0.035; p = 0.0002). Super-
oxide generation from RGC-5 and SK-N-AS cells was
measured after the addition of glutamate/malate. There
was a large increase in superoxide production after the
addition of glutamate/malate to SK-N-AS mitochondria
(0.560 ± 0.054; p < 0.0001 compared to no substrate),
similar to what was seen with cerebral and RGC-5 mito-
chondria. After the addition of rotenone there was a sig-
nificant decrease in superoxide production in SK-N-AS
cells (0.383 ± 0.050; p < 0.0001 compared to substrate
alone), unlike what was seen with cerebral or RGC-5 cells.
In experiments where the complex II substrate was added
to neuroblastoma mitochondria, there was a minimal
change in production of superoxide (0.348 ± 0.042 to
0.307 ± 0.024; p = 0.08), similar to cerebral and RGC-5
mitochondria. The addition of antimycin A to neuroblas-
toma mitochondria resulted in a small but significant
decrease in superoxide production (0.277 ± 0.034; p =
0.026 compared to substrate alone), similar to RGC-5
mitochondria but different from the increase in superox-
ide seen in cerebral mitochondria. In all cases, the rates of
superoxide production by neuroblastoma mitochondria
were much higher than RGC-5 mitochondria.
Mitochondria isolated from RGC-5, neuroblastoma SK-N-
AS, and cerebrum differ in content of METC components
Most mitochondrial superoxide is produced by the METC.
To determine if differences in superoxide production
among mitochondria from different neuronal subtypes
could be caused by differences in the METC, we measured
the relative amounts of METC complexes for protein con-
centration-corrected mitochondrial isolates. Immunob-
lots against specific METC complex subunits were scanned
by densitometry and normalized to concentrations from
cerebral mitochondria (Figure 5 and Table 5). The most
surprising finding was that RGC-5 mitochondria con-
tained only one-sixteenth as much METC complex I as
was present in cerebral cells. Complex II, III, and IV com-
ponents were expressed at a molar concentration in RGC-
5 mitochondria about half that of cerebral mitochondria.
Neuroblastoma mitochondria had similar levels of com-
plexes I-IV, ranging from 16% to 46% that of brain.
We considered the possibility that different physical prop-
erties of cells or mitochondria might produce differential
purification of mitochondria. The primary organelles co-
purified with mitochondria are peroxisomes. To investi-
gate the possibility that peroxisomal contamination could
decrease the number of mitochondria with the prepara-
tions, we immunoblotted protein-corrected mitochon-
drial isolates for the peroxisomal protein PMP70. There
were similar amounts of PMP70 in the mitochondria
purified from RGC-5 cells, neuroblastoma cells, and cere-BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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bral cells (Figure 5 and Table 5), ruling out differential
peroxisomal contamination as the cause of lower METC
components in RGC-5 cells. We then compared mito-
chondrial isolates from the different cell types for a non-
METC mitochondrial protein, the voltage-dependent
anion channel (VDAC). There was a small decrease in
VDAC expression in mitochondria isolated from RGC-5
cells in comparison to cerebral and neuroblastoma cells,
but not enough to explain the significant difference in
complex I expression.
We used real-time RT-PCR to compare mRNA levels of
mitochondrial electron transport chain complexes I, II, III,
IV, V, SOD-2, PMP-70, and VDAC to see if cell type-spe-
cific gene transcription levels correlated with protein lev-
els. When normalized to VDAC expression, all METC
subunits were downregulated in both undifferentiated
and differentiated RGC-5 cells (Table 6). In general, differ-
ences in mRNA levels between cell-types correlated with
differences in protein levels. Surprisingly, complex I
(alpha subunit, 9) transcription levels were higher in
brain than RGC-5 cells, but this difference was not seen to
the same degree in protein levels, measured by immuno-
blotting. On the other hand, complex IV (subunit 1) tran-
scription levels were much lower than the difference in
protein levels would predict (Figure 6). Differentiation of
RGC-5 cells had a minimal effect on transcription levels of
all genes studied.
Discussion
Mitochondria isolated from the RGC-like RGC-5 cell line
produce significantly less superoxide than cerebral and
neuroblastoma mitochondria when incubated with com-
plex I or II substrates or when treated with complex I or III
inhibitors. Correspondingly, RGC-5 mitochondria con-
tain significantly lower levels of complex I compared to
Superoxide Production in Cerebral, Neuroblastoma, and RGC-5 Mitochondria after Complex III inhibition Figure 4
Superoxide Production in Cerebral, Neuroblastoma, and RGC-5 Mitochondria after Complex III inhibition. 
Mitochondria isolated from cerebral, neuroblastoma, and undifferentiated RGC-5 cells were normalized for protein content 
and superoxide production was analyzed after the addition of the complex II substrate succinate and the complex III inhibitor 
antimycin A. The mitochondrial superoxide production levels in cerebral cells were significantly higher than that of undifferen-
tiated RGC-5 cells in the presence of succinate and after complex III inhibition with antimycin A. Both succinate and antimycin 
A elicited minimal superoxide production in undifferentiated RGC-5 cells, while in cerebral cells there was a near two-fold 
increase in superoxide production after the addition of antimycin A.
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other METC components, despite similar levels of tran-
scription. Together, these findings imply that neuronal
mitochondria behave differently depending on the cell of
origin.
Overall, the rate of superoxide production of RGC-5 cell
mitochondria was much less than that of cerebral mito-
chondria for a given amount of mitochondrial protein.
Comparing the rates of production in the absence of sub-
strates and inhibitors, basal cerebral mitochondria super-
oxide production was seven times of that of RGC-5 cells.
The most notable differences after METC inhibition was
the increased superoxide production in cerebral mito-
chondria in the presence of the complex III inhibitor
antimycin A. After treatment with antimycin A, cerebral
mitochondria had a more than 2-fold increase in superox-
ide production, compared to an insignificant decrease in
superoxide production rate in RGC-5 mitochondria.
The difference in superoxide production is not a result of
RGC-5 cells being undifferentiated mitotically active cells.
We previously showed that low-dose staurosporine, a
broad spectrum protein kinase inhibitor, can induce RGC-
5 cells to differentiate to a phenotype that is similar to a
mature RGC [14]. To see if differentiation affected ROS
production, we compared superoxide production in dif-
ferentiated and undifferentiated RGC-5 cells. Differenti-
ated and undifferentiated RGC-5 produced similar
amounts of superoxide in the presence of complex I sub-
strates and inhibitors and only differed slightly in super-
oxide production after incubation with succinate, a
complex II substrate, in the presence of the complex III
inhibitor antimycin A. Differences in superoxide produc-
tion between mitochondria from RGC-5 cells and cerebral
cells were also not due to differences in the source of the
tissue (a cell line vs. fresh tissue), because similar differ-
ences were seen when RGC-5 cells were compared to a
neuroblastoma cell line. Finally, the differences were also
not a result of differential purification of mitochondria, as
the levels of the peroxisomal-associated protein PMP70
were similar across cell-type.
There are limitations to our study. We did not measure
superoxide directly, instead indirectly measuring superox-
ide generation using the H2O2 probe Amplex Red. Indirect
superoxide measurement with a probe specific for H2O2 is
Table 3: Superoxide Production in Mitochondria from Differentiated and Undifferentiated RGC-5 Cells in the Presence of a Complex I 
Substrate and Inhibitor.
Undifferentiated RGC-5 Differentiated RGC-5
N = 8 N = 2
Mean SEM Mean SEM
Mitochondria 0.030 0.004 0.033 0.004
Glutamate/Malate 0.046 0.004 0.052 0.003
Rotenone 0.048 0.004 0.055 0.003
The rates of superoxide production were determined after the addition of the complex I substrates glutamate (10 mM) and malate (5 mM) and the 
complex I inhibitor rotenone (6.7 µM). Superoxide was indirectly measured using the H2O2 probe Amplex Red in the presence of horseradish 
peroxidase (HRP). The values are given in nmol H2O2/min/mg protein ± standard error of the mean (SEM), with n being the number of independent 
samples for each mitochondria type.
Table 4: Superoxide Production in Mitochondria from Differentiated and Undifferentiated RGC-5 Cells in the Presence of a Complex 
II Substrate and a Complex III Inhibitor.
Undifferentiated RGC-5 Differentiated RGC-5
N = 8 N = 2
Mean SEM Mean SEM
Mitochondria 0.028 0.005 0.041 0.002
Succinate 0.031 0.005 0.037 0.001
Antimycin A 0.024 0.004 0.040 0.002
The rates of superoxide production were determined after the addition of the complex II substrate succinate (10 mM) and the complex III inhibitor 
antimycin A (0.5 µM). Superoxide was indirectly measured using the H2O2 probe Amplex Red in the presence of horseradish peroxidase (HRP). 
The values are given in nmol H2O2/min/mg protein ± standard error of the mean (SEM), with n being the number of independent samples for each 
mitochondria type.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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commonly performed [15,16] because mitochondrial
superoxide dismutase (SOD-2) converts superoxide to
H2O2, and the latter freely crosses organelle and cell mem-
branes. Amplex Red reacts with H2O2 in the presence of
HRP and is converted to the fluorescent product resorufin.
In these experiments we detected changes in the levels of
resorufin and used them to determine the production
rates of superoxide. The production of hydrogen peroxide
by complex I does not necessarily require dismutation
[17]. suggesting that measuring levels of H2O2  is an
acceptable method for measuring superoxide production
or leakage from complex I. Nonetheless, we cannot
exclude the possibility that abnormally low SOD-2 activ-
ity biased our results.
We also examined superoxide production in mitochon-
dria obtained from the RGC-5 cell line, and not from
freshly isolated RGCs. It is possible that some of the dif-
ferences that we measured in superoxide generation arose
because the cerebral mitochondria were isolated from
whole cerebral tissue and the RGC-5 mitochondria were
isolated from a clonal cell line. The environment of the
RGC-5 is normoxic, being exposed to atmospheric partial
pressure of oxygen, compared to the relatively hypoxic
environment within the brain. Also, cerebral mitochon-
dria were isolated from a mixture of cell types, not only
neuronal, but also glial cells, and this could blur differ-
ences between the cerebral and RGC-5 mitochondria.
Purifying a usable quantity of mitochondria from freshly
isolated RGCs is impractical, and thus the use of a differ-
entiable RGC cell line allows otherwise unfeasible mito-
chondrial studies. Difficulties in isolation of
mitochondria from RGCs include the large numbers of
animals necessary to obtain enough RGCs (there are
approximately 105 RGCs per rat retina) and subsequently
obtaining mitochondria from a small number of purified
RGCs. It is impractical to do mitochondrial metabolic
experiments from freshly isolated RGCs, as discussed
above, and whole retina cannot be used because RGCs
make up only a small fraction of the tissue.
Low levels of superoxide production in RGCs compared
to cerebral and neuroblastoma cells could be due to
decreased flow of oxygen through the METC, decreased
leakage of superoxide from the METC, or increased scav-
enging via non-SOD mechanisms (increased scavenging
via SOD would increase H2O2 levels in our assay). Our
experimental design could not distinguish these possibil-
ities. The explanation is not simply one of lower METC
density in RGCs. Immunoblotting demonstrated that
there was markedly less mitochondrial complex I in RGC-
5 cells compared to cerebral and neuroblastoma cells,
while levels of complexes II, III, and IV were similar. Anal-
ysis of transcription levels confirms lowered gene expres-
sion of these complexes in RGC-5 cells compared to
cerebral cells. If there were also lower amounts of other
METC components in RGC-5 cells, then this could explain
why RGC-5 mitochondria produce less superoxide. How-
ever, if the differences in superoxide were simply a matter
of lower concentration of METC components, then this
could explain differences in baseline superoxide produc-
tion, but would not explain differences in patterns of
superoxide induction, e.g. why there was such a large
increase in superoxide production in cerebral mitochon-
dria but not RGC-5 cells after treatment with antimycin A.
It has been shown that superoxide production by isolated
succinate dehydrogenase is highly dependent on succi-
nate concentration, with superoxide generation increas-
ing, then decreasing with succinate concentration [18].
Lower expression of succinate dehydrogenase and other
METC components, as suggested by our immunoblotting
and RT-PCR data, may lead to succinate blocking autoox-
idation at a lower concentration in RGC-5 cells compared
to cerebral cells. Another possibility relates to the fact that
antimycin A leads to increased superoxide production by
backflow of electrons into complex I. If complex I levels
are lower in RGC-5 cells, then this would lead to less
superoxide production after antimycin A treatment in
those cells.
We speculate that decreased production of superoxide by
RGCs may have a physiological rationale. We previously
demonstrated RGCs use superoxide as a mitochondrial-
derived intracellular messenger for signaling the initiation
of apoptosis after axonal injury [10]. If RGCs use superox-
ide to signal cell death, then it is reasonable to presume
Table 5: Density Comparison of METC Components in Cerebral, Neuroblastoma, and Undifferentiated RGC-5 Mitochondrial 
Samples.
Complex I Complex II Complex III Complex IV VDAC PMP70
Cerebral 111111
Neuro-blastoma 0.258 0.456 0.158 0.224 1.625 1.032
RGC-5 0.056 0.654 0.533 0.561 0.599 0.797
The band density of mitochondrial related proteins were compared between cerebral, neuroblastoma, and RGC-5 derived mitochondrial samples 
for METC complexes I-IV. A comparison of VDAC and PMP70 expression were used to determine the presence of non-METC mitochondrial 
components and peroxisomal contamination, respectively. Cerebral, RGC-5, and neuroblastoma values are given as ratios compared to the band 
density of cerebral mitochondria.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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Immunoblotting of Mitochondrial Components Figure 5
Immunoblotting of Mitochondrial Components. Isolated mitochondrial samples standardized for protein content were 
compared to corresponding mitochondria depleted samples for the presence of the mitochondrial membrane proteins Com-
plexes I-IV, and VDAC. Standardized mitochondrial preparations were also investigated for the peroxisomal marker PMP70. 
Samples were subject to an electrophoresis and were transferred overnight to nitrocellulose. Samples were incubated with a 
mouse a primary antibody corresponding the protein of interest, and subsequently treated with an HRP-conjugated antibody. 
Each mitochondrial protein shows that there is considerable purification of mitochondria compared to the mitochondria 
depleted samples for cerebral, neuroblastoma, and undifferentiated RGC-5 cells. There is a nearly 18-fold increase in the 
expression of complex I in cerebral cells compared to RGC-5. Similar levels of expression in PMP70 and complex II were seen 
in all three samples.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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that they also tightly regulate its intracellular concentra-
tion in relevant compartments. Otherwise there would be
death of a critical (and non-renewable) class of neurons.
Loss of this tight regulation of superoxide production
could also explain the mechanism of RGC death from
mtDNA mutations in LHON. Although it is commonly
believed that LHON results from RGCs having high-
energy requirements, with mtDNA mutations causing
RGC-specific death because the cell cannot meet its energy
demands. However, this theory does not clearly address
why there is little neuronal loss in other high-energy cells
such as photoreceptors or cardiac muscle (as is seen in
some mtDNA deletions), nor does it explain the delayed
onset of LHON. Most importantly, there is a discrepancy
between the degree of ATP deficiency and the severity of
the optic neuropathy in cells with LHON mutations [19].
Instead, it is more likely that differences in ROS produc-
tion and sensitivity to oxidative stress among cells types
explains the timing and the specificity of LHON. There are
precedents for cell type-specific differences in mitochon-
drial superoxide production. Rat brain and liver mito-
chondria differ in superoxide production in the presence
of METC substrates and inhibitors [20]. Cardiac mito-
chondria from birds and mice have dramatically different
rates and sites of H2O2 production [21]. Finally, LHON
cybrids in neuronal-like differentiated NT2 cells have
greatly increased superoxide production [6]. It makes
sense that ROS would be involved in LHON because the
mutations are in known superoxide production sites [22],
inhibition of these sites dramatically increases superoxide
synthesis [15], and neuronal cybrids with LHON muta-
tions have increased superoxide production [6]. In cere-
bral mitochondria, complex I produces the majority of
superoxide radicals [16], and the same may be true for
RGCs [10]. If RGC mitochondria have insufficient mech-
anisms for reducing levels of superoxide production, par-
ticularly in response to METC inhibition, then mutations
of critical complex I components could theoretically lead
to catastrophic superoxide production and anomalous
signaling of cell death in the absence of axonal damage
[10]. Lower METC component expression and basal
superoxide production in RGCs may be accompanied by
a similar downregulation in SOD2 or other ROS-reducing
systems, leading to a phenotype which is overwhelmed
more readily than other cells in the event of aberrant
superoxide generation.
Conclusion
Mitochondria from a RGC-like cell line produced super-
oxide at a much lower rate than cerebral or neuroblast-
Table 6: Relative transcription levels of METC components
Gene Subunit RGC-5 RGC-5 +SS
VDAC - ∆Ct -1.78 -1.73
∆(∆Ct) 0.0 0.0
Relative Expression 1.0 1.0
SOD2 - ∆Ct 1.57 1.83
∆(∆Ct) 3.35 3.67
Relative Expression 0.098 0.08
PMP70 - ∆Ct 1.30 1.60
∆(∆Ct) 3.08 3.33
Relative Expression 0.118 0.099
C I NDUFA9 ∆Ct 0.88 0.67
∆(∆Ct) 2.67 2.40
Relative Expression 0.157 0.189
C II SDHA ∆Ct 4.49 3.33
∆(∆Ct) 6.28 5.07
Relative Expression 0.013 0.030
C III UQCRC2 ∆Ct 3.80 2.92
∆(∆Ct) 5.58 4.65
Relative Expression 0.021 0.039
C IV MTCO1 ∆Ct 9.58 7.38
∆(∆Ct) 11.37 9.12
Relative Expression 0.00038 0.0018
C V ATP5A1 ∆Ct 0.48 0.98
∆(∆Ct) 2.27 2.72
Relative Expression 0.208 0.152
Changes in transcription levels of each gene studied are given in terms of the difference in threshold cycle compared to cerebral cells(∆Ct), the 
difference in threshold cycle relative to that of VDAC (∆(∆Ct)), and the relative expression level, given as a percent of cerebral and normalized to 
VDAC expression.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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oma mitochondria, and there was a dramatic difference in
superoxide production when electrons were shunted to
complex I using METC complex I and III substrates and
inhibitors. These differences were mirrored by different
patterns of METC component expression between cell
types. Decreased superoxide production may be essential
for preventing aberrant signaling of cell death in RGCs.
Mutations coding for specific components of NADH-ubi-
quinone oxidoreductase in LHON may disrupt the cell
type-specific handling of superoxide in RGC mitochon-
dria and lead to premature cell death. This could explain
why LHON mtDNA mutations are present in all cells, but
the clinical phenotype is predominantly one of RGC
death.
Methods
Animals
Cerebral mitochondria were obtained from adult Long-
Evans rats. All animals were used in accordance with fed-
eral, state, and institutional guidelines for the use of ani-
mals in laboratory research.
Materials
Staurosporine (from Streptomyces staurosporeus;  ≥ 98%
purity; catalog number 380-014) was obtained from
Alexis Biochemicals (San Diego, CA. Cell culture reagents,
unless noted, were obtained from BioWhittaker (Rock-
land, ME). All labeled antibodies and fluorescent dyes
were obtained from Molecular Probes (Eugene, OR),
Sigma (St. Louis, MO), Jackson ImmunoResearch Labora-
tories (West Grove, PA), and Abcam (Cambridge, MA).
Rotenone and 3-(4,5-dimethylsulfoxide (DMSO) was
obtained from Sigma (St. Louis, MO). Antimycin A was
from Fisher Scientific (Hampton, NH). Mitochondria iso-
lation materials and protease inhibitors were from Pierce
Biotechnology (Rockford, IL).
Solutions
Amplex Red solution consisted of 100 µM Amplex Red
reagent, 0.2 U/ml horseradish peroxidase (HRP), and
0.05 M sodium phosphate. Mannitol, tris-HCl, and potas-
sium chloride (MTP) solution consisted of 110 mM man-
nitol, 60 mM Tris-HCl, 60 mM KCl, 10 mM KH2PO4, 0.5
mM EDTA, pH 7.4.
Cell Culture and Differentiation
The RGC-5 cell line was generously provided by Dr.
Neeraj Agarwal of the University of North Texas. RGC-5
cells were cultured in DMEM (Mediatech, Inc.; Herndon,
CA) containing 1 gm/L glucose with L-glutamine, supple-
mented with 10% fetal bovine serum, 100 U/ml penicil-
lin, and 100 µg/ml streptomycin. Cells were incubated at
37°C in humidified 5% CO2. To induce differentiation
some RGC-5 were treated with staurosporine (316 nM) 24
hours prior to mitochondria isolation. The neuroblast-
Quantitative Real-Time RT-PCR of Mitochondrial Compo- nents and Associated Proteins Figure 6
Quantitative Real-Time RT-PCR of Mitochondrial 
Components and Associated Proteins. Amplification 
curves for (A) VDAC, (B) Complex I, and (C) Complex IV. 
Solid black lines indicate undifferentiated RGC-5 cells, long 
dashes indicate differentiated RGC-5 cells, and short dashes 
indicate cerebral cells. The fuzzy line denotes the template-
free control. The horizontal gray line indicates the calculated 
threshold value by which Ct is determined.
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oma SK-N-AS line was obtained from Dr. Arthur Polans of
the University of Wisconsin (Madison). Cells were cul-
tured in RPMI 1640, supplemented with 10% fetal bovine
serum, 10 mM HEPES, penicillin 100 U/ml, streptomycin
100 µg/ml, and amphotericin B 0.25 µg/ml.
Isolation of RGC-5 and Neuroblastoma SK-N-AS 
Mitochondria
Cells were treated with trypsin-EDTA to allow detachment
from growing flasks, centrifuged 7 minutes at 250 × g at
4°C. Mitochondria were isolated from the pellet using the
Pierce Mitochondria Isolation Kit for Mammalian Cells
(Pierce Biotechnology, Rockford, IL, Prod # 89874) using
the reagent-based protocol. Briefly, cells were treated with
reagents in the presence of Pierce Halt Protease Inhibitor
Cocktail, EDTA free (Prod # 78415) and were subject to a
series of graded centrifugations. To maintain the integrity
of the mitochondria, samples were kept on ice during the
isolation process. The mitochondrial pellet was sus-
pended in MTP medium and remained on ice until analy-
sis of mitochondrial activity was performed.
Isolation of Cerebral Mitochondria
Long-Evans rats were euthanized with CO2  gas and
approximately 100–200 mg of the frontal cortex removed.
The tissue was washed with ice-cold PBS and a mitochon-
drial isolation kit for soft tissues (Pierce, Prod # 89801)
was used. Briefly, the brain tissue was cut into small pieces
and added to a cold Dounce homogenizer containing
PBS. The tissue was homogenized using 7–10 strokes of
the homogenizer. The homogenate was then centrifuged
per protocol and the resultant mitochondrial pellet sus-
pended in MTP and kept on ice until analyzed.
Protein Content of Mitochondrial Preparations
Isolated mitochondria pellets were suspended in MTP and
the protein content of the isolated mitochondria deter-
mined by Bradford assay. For each experiment protein
concentrations were adjusted so that each mitochondrial
sample had the same protein content.
MitoTracker Green FM Quantification of Mitochondrial 
Preparations
The fluorophore MitoTracker Green FM was used as a sec-
ondary method to verify that the mitochondrial content
was similar between cell types. MitoTracker Green FM
becomes a fluorescent thiol-conjugate (excitation 490
nm/emission 515 nm) after oxidation in the lipid mem-
brane of mitochondria. Solutions containing mitochon-
dria were treated with MitoTracker Green FM (0.5 µM) in
a 1:1 ratio and were allowed to aggregate fluorescent prod-
uct for 30 minutes in a 96-well plate. Fluorescence was
then compared between cell type mitochondria using a
Wallac Victor2 1420 multilabel counter with appropriate
filters.
Mitochondrial Electron Transport Chain Content of 
Mitochondrial Preparations
Mitochondrial enriched and depleted (i.e. cytoplasm)
samples obtained from the final supernatant of the mito-
chondria isolation procedure were stored in NuPage LDS
sample buffer with reducing agent (Invitrogen). The pro-
tein concentrations of the isolated mitochondria were
determined by Bradford assay, and equal amounts of pro-
tein for each mitochondrial preparation were boiled in
the presence of 4× lithium dodecyl sulfate (LDS) sample
buffer (Invitrogen, Carlsbad, CA) plus 5% β-mercaptoeth-
anol, resolved on a Bis-Tris 4% to 12% polyacrylamide gel
(NuPAGE; Invitrogen), and transferred overnight at 50
mA to nitrocellulose membrane in a transfer apparatus
(Mini Protean II; Bio-Rad Laboratories, Hercules, CA).
After transfer, the membrane was blocked with 0.5% non-
fat milk in TBS (pH 8.0) for 30 minutes and then individ-
ually probed with mouse monoclonal antibody to
NADH:ubiquinone oxidoreductase α subcomplex, 9
(complex I; 1:2,000; Molecular Probes, Eugene, OR),
mouse monoclonal antibody to succinate dehydrogenase
flavoprotein (complex II; 1:2,500; Molecular Probes,
Eugene, OR), mouse monoclonal antibody to ubiqui-
none:cytochrome c oxidoreductase core III (complex III;
Molecular Probes, Eugene, OR), mouse monoclonal anti-
body to cytochrome C oxidase subunit I (complex IV;
1:1000; Molecular Probes, Eugene, OR), rabbit mono-
clonal antibody to voltage dependent anion channel 1/
porin (VDAC; 1:500; Sigma, St. Louis, MO), or rabbit
monoclonal antibody to PMP70 (1:2000; Abcam, Cam-
bridge, MA). Blots were rinsed three times with TBS con-
taining 0.05% Tween-20 (Fisher Scientific), then washed
5 times for 10 minutes each at room temperature on an
orbital shaker. Secondary antibodies used were horserad-
ish peroxidase (HRP)-conjugated goat anti-mouse IgG
(1:5000; Jackson ImmunoResearch Laboratories, West
Grove, PA) or purified horseradish peroxidase (HRP)-con-
jugated goat anti-rabbit IgG (1:5000; Jackson ImmunoRe-
search Laboratories, West Grove, PA) and were incubated
for 1 hour at room temperature, followed by 3 rinses and
five 10-minute washes with TBS containing Tween-20 at
room temperature on an orbital shaker. Blots were treated
with freshly prepared ECL solution containing 100 mM
Tris-HCl (pH 8.5), 1.25 mM luminol, 225 µM p-coumaric
acid (Sigma-Aldrich), and 1 mM H2O2 Fisher Scientific)
for 1 minute, and excess solution was allowed to drip off.
The blots were then exposed to film (BioMax XAR; East-
man Kodak Company, Rochester) and developed. The
films were scanned at 1600 dpi and band density was
determined by comparing total intensity in an area con-
taining the band of interest to the intensity of an equal
size area of background using NIH ImageJ software. Band
density readings are presented with respect to the density
of the band from cerebral mitochondria.BMC Neuroscience 2008, 9:4 http://www.biomedcentral.com/1471-2202/9/4
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RT-PCR Analysis of Expression of Components of the 
Mitochondrial Electron Transport Chain
Total RNA was isolated from 0.5–1.0 × 106 RGC-5 cells,
differentiated RGC-5 cells, and rat brain using the RNeasy
Protect Mini Kit (Qiagen; Valencia, CA). Freshly prepared
RNA samples were immediately transcribed to cDNA
using the iScript cDNA Synthesis Kit (Bio-Rad; Hercules,
CA) and quantitative real-time PCR was carried out with
primers to each gene subunit analyzed by Western blot-
ting (Table 7) using the iScript One-Step RT-PCR Kit with
SYBR Green, omitting reverse transcriptase. Primers were
either taken from previously published papers or designed
using Primer Express (Applied Biosystems; Foster City,
CA). Specificity was confirmed by searching against rat
genomic and expression nucleotide databases. Samples
were cycled 45 times for 15 sec at 95°C and 30 sec at
55°C, followed by 1 min at 95°C and 1 min at 55°C. Melt
curve analyses were performed, and single peaks observed
in all cases.
Threshold cycle (Ct) was computed automatically by the
iCycler software (Bio-Rad), and compared across all con-
ditions. Delta Ct (∆Ct) was computed for each gene with
respect to brain for each cell line studied, and normalized
for VDAC expression by subtracting the ∆Ct for VDAC in a
particular cell type from the ∆Ct for each other gene in that
cell type (∆(∆Ct)). This difference indicates the -(log2) dif-
ference in RNA copy number.
Superoxide Measurements
Superoxide was indirectly measured by assaying H2O2
[15,16], the product of superoxide dismutation by mito-
chondrial SOD-2. The fluorescent product of Amplex Red
and H2O2 was analyzed in various conditions in duplicate
to quadruplicate. All assays were performed in 96-well
plates and read with a Wallac Victor2 1420 multilabel
counter using the appropriate filters (excitation 535 nm/
emission 580 nm). To each well Amplex red solution was
added and a time-lapse fluorescent baseline was estab-
lished in the absence of mitochondria. Consecutively, to
the well containing Amplex red was added an equal vol-
ume of cerebral, RGC-5, or neuroblastoma mitochondria,
a substrate (glutamate/malate or succinate), and an inhib-
itor of the METC (rotenone or antimycin A). All figures are
expressed in nmol/min/mg protein, assuming full super-
oxide dismutation. All experiments were repeated 2–4
times.
Statistical Analysis
Comparisons between different groups were by Student's
unpaired t-test, while comparisons between serial treat-
ments of mitochondria with substrate or inhibitors were
by Student's paired t-test. Significant differences required
p < 0.05.
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Table 7: Primers Sequences used for RT-PCR Analysis and Expected Product Sizes
Gene Subunit Primer Sequence 5'-3' PCR Product
SOD2 - F: ATT AAC GCG CAG ATC ATG CA 89 bp
R: TCG TGG TAC TTC TCC TCG GTG A
VDAC - F: ATG CCT GCT TTT CGG CCA A 118 bp
R: GCT GGA TGG CAA GAA CGT CAA
PMP70 - F: CTC GGC CTG CAC GGT AAG 78 bp
R: CAC AGC TCG CTC TTT CTT TCC T
C I NDUFA9 F: TTG TCA ACC ATC TTG GAC GAA T 166 bp
R: TTG CTG TGC TGC ACT GCT TTC
C II SDHA F: GAG GAA GCA CAC CCT CTC ATA 101 bp
R: TAG CAC AGT CAG CCT CAT TCA A
C III UQCRC2 F: AAA TTG ACG CTG TGG CTG ATG 101 bp
R: AGG CGT ATG TCC CAA GTT TCC
C IV MTCO1 R: AGC CCC TGA TAT AGC ATT CCC 116 bp
F: TTC ATC CTG TTC CAG CTC CAG
C V ATP5A1 F: CTT ATC CAA GCA GGC TGT TGC 134 bp
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